IV Iron Replacement Might Be Easier, More Effective Treatment For Iron Deficiency Anemia

By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 13, 2026 (HealthDay News) — Women with iron deficiency anemia caused by ...

Safe, low-cost Alzheimer's drug demonstrates efficacy against sickle cell anemia

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...
MedPage Today on MSN

Autoimmune Anemia Is the Latest Condition Found Responsive to CAR-T Therapy

Eleven patients with refractory autoimmune hemolytic anemia (AIHA) were all brought into drug-free remission with CAR T-cell ...
Medindia

FDA Approves Mitapivat- First Oral Treatment for Anemia in Thalassemia

Mitapivat is the first FDA-approved oral therapy for anaemia in all forms of thalassemia Reduced transfusion dependence may ...
Medical Dialogues

CAR T-Cell Therapy Shows Promise in Autoimmune Hemolytic Anemia: Study

China: CAR T-cell therapy, already in use for certain B-cell–driven autoimmune diseases such as lupus, has now demonstrated ...
St. Louis American

Dialysis patients with sickle cell trait require more anemia drugs

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up The presence of sickle cell trait among African Americans may ...
Reuters

For-profit dialysis more aggressive on anemia drugs

CHICAGO, April 17 (Reuters) - For-profit dialysis chains treating the bulk of kidney disease patients in the United States are more aggressive in using lucrative anemia drugs, compared with their ...
Medindia

FDA Approves First Oral Drug for Thalassemia Anemia

FDA approves Mitapivat, the first oral treatment for thalassemia anemia, helping reduce transfusion needs and raise ...